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Abstract Urolithiasis and nephrocalcinosis are more fre-
quent in children then currently anticipated, but still remain
under- ormisdiagnosed ina significant proportionofpatients,
since symptoms and signs may be subtle or misleading. All
children with colicky abdominal pain or macroscopic hema-
turia should be examined thoroughly for urolithiasis. Also,
other, more general, abdominal manifestations can be the first
symptoms of renal stones. The patients and their family
histories,aswellasphysicalexamination,are important initial
stepsfordiagnosticevaluation.Thereafter,diagnosticimaging
should be aimed at the location of calculi but also at
identification of urinary tract anomalies or acute obstruction
due to stone disease. This can often be accomplished by
ultrasound examination alone, but sometimes radiological
methods such as plain abdominal films or more sensitive non-
enhanced computed tomography are necessary. Since meta-
bolic causes are frequent in children, diagnostic evaluation
should be meticulous so that metabolic disorders that cause
recurrent urolithiasis or even renal failure, such as the primary
hyperoxalurias and others, can be ruled out. The stone is not
the disease itself; it is only one serious sign! Therefore,
thorough and early diagnostic examination is mandatory for
every infant and child with the first stone event, or with
nephrocalcinosis.
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Introduction
Different incidence rates and aetiological factors are
reported in children with urolithiasis or nephrocalcinosis,
reflecting differences in geographic, genetic and socioeco-
nomic background as well as the source of the series and
the study design [1].
While the exact rates for nephrocalcinosis are unknown,
the incidence of urolithiasis in childhood is believed to be
approximately 10% of that in adults, which is around 5% in
industrialized countries [2]. Since a significant proportion
of patients remains undiagnosed or misdiagnosed (incidental
discovery reported in 15–40%), numbers should be inter-
preted with caution [3]. In specific parts of the world
prevalence rates are significantly higher and compare to
those of adults [4]. Urolithiasis appears in all pediatric age
groups, but a male predominance analogous to that in adult
patients is observed. However, urolithiasis in childhood
differs substantially from that in adults with regard to
aetiology, symptoms and signs, imaging techniques and
treatment [5, 6]. Approximately 40% of children with
urolithiasis have a positive family history of kidney stones,
and most of the children have a metabolic background of
stone disease. Hence, specific and intensive diagnostic
examination is necessary for every child experiencing even
a single kidney stone event, to prevent recurrence of disease
or even a disastrous outcome with kidney failure and
end-stage renal disease [7].
Systematic diagnostic evaluation starts with a detailed
medical history, followed by careful imaging studies
(primarily avoiding plain X-ray) and specific urine analysis
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tion of the pathophysiological background of stone disease
[8], in order to initiate early and appropriate treatment to
prevent recurrence. In this respect it always has to be kept
in mind that kidney stone(s) or nephrocalcinosis are the sign
(s) of the disease, but not the disease itself! The following
teaching paper details the necessary steps of diagnostic
examination of the child with stones or nephrocalcinosis.
The stepwise procedure is also shown in Table 1.
Medical history
Obtaining a thorough medical history followed by a careful
physical examination seems to have become a lost art, but
it is indispensable for early and correct diagnosis. It is
important to obtain information from the family on stones,
hematuria andrenal failure,andonmetabolic diseases(draw a
pedigree chart). Particular attention has to be paid to nutrition
or specific diets, fluid intake (dehydration), medications
(vitamins D/A, steroids, diuretics, etc.), immobilization, and
any mineral supplementation. Children with chronic bowel
disease (e.g. Crohn’s disease, cystic fibrosis, post-bowel
resection), neurologic disorders (anti-convulsant drugs, low
fluid intake) or with anomalies of the urinary tract predispos-
ing to urine stasis and urinary tract infection (neurogenic
bladder, ileal loops, megaureter, megacalycosis, hydoneph-
rosis) are at special risk for stone formation (Table 2).
Clinical findings (physical examination)
Symptoms of urinary tract stones are often non-specific,
particularly in infants and young children [5, 9]. In
addition, stones may remain asymptomatic for long periods
of time. The most common symptom of urolithiasis is
abdominal pain, in older children clearly identifiable as
colicky pain, in infants and children, however, only
recognized as “non-specific” abdominal pain and thus
difficult to differentiate from acute appendicitis, etc. [10].
Unexplained sterile pyuria or recurrent urinary tract
infections (UTIs) should raise the level of suspicion for
urolithiasis, especially in the younger child. Gross or
microscopic—non-glomerular—hematuria and, more rarely,
flank tenderness or urinary retention are other symptoms
encountered. Gross hematuria may be present for some time
before urolithiasis or nephrocalcinosis become manifest.
Sometimes there are secondary gastro-intestinal tract symp-
toms such as vomiting, flatulence or constipation.
Symptoms differ according to the location of the stone.
Stones of the lower urinary tract may manifest themselves
by dysuria, voiding problems or complete urine retention,
but enuresis, frequent voiding, hematuria and fever may
also be diagnostic hints. Also, manipulation of genitals in
younger children may be a first sign of urolithiasis of the
urethra. In infants, especially, stones may become stuck and
therefore palpable in the urethra, such that the first
symptom of stones is inability to pass urine [5]. Stones
may even be the first symptom in polycystic kidney disease,
especially in the autosomal dominant form, and hence
palpable kidneys may lead way to diagnosis.
A missed diagnosis may have serious consequences. For
example, diagnosis of primary hyperoxaluria is often only
made after end-stage renal failure has occurred years or
decades after the first symptom of nephrolithiasis had
appeared [11].
In contrast to nephrolithiasis, nephrocalcinosis is mostly
asymptomatic, especially during infancy and early child-
Table 1 Diagnostic steps in urolithiasis (UTI urinary tract infection, CT computed tomography, MRI magnetic resonance imaging, PTH
parathyroid hormone, pCO2 partial pressure of carbon dioxide)
Step Diagnostic findings
History, including family history Diet, fluid intake, medication, vitamin supplementation
Chronic diseases? Malabsorption syndromes?
Immobilization?
Clinical findings Pain, hematuria, vomiting, UTI
Passage of stones, gravel
Imaging Ultrasonography, (plain film)
Non-contrast-enhanced CT, (MRI)
(Intravenous urography)
Urine Density, specific gravity (osmolality), pH, glucose, protein, sediment, culture
Spot urine: molar creatinine ratios of calcium, oxalate, uric acid, citrate, magnesium
Cystine screening (nitroprusside test, amino acid screen)
24 hour urine: volume, pH; (lithogenic and stone-inhibitory parameters); calculation of urinary saturation
Blood/serum Electrolytes, calcium, phosphorus, magnesium, creatinine, urea, uric acid, alkaline phosphatase, (PTH,
vitamins D/A, plasma oxalate, serum vitamin B6 level)
Acid-base status (pH, pCO2, base excess and/or standard bicarbonate)
Stone analysis Infrared spectroscopy or X-ray diffraction
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406 Pediatr Nephrol (2010) 25:403–413hood. Hence, diagnosis is often only made when neph-
rocalcinosis is incidentally noted on an imaging study
performed for other reasons or when symptoms of reduced
concentrating capacity of the renal tubules are obvious.
However, the underlying pathological condition is not
always evident and requires a detailed history and work-
up. Renal colic has been reported in some infants with
nephrocalcinosis, but it is more likely due to passage of tiny
calculi than to nephrocalcinosis per se. It is not unusual for
nephrocalcinosis to be diagnosed during systematic renal
ultrasound examination of high-risk infants or as part of the
diagnostic evaluation of urinary tract infection. The first
clinical symptoms, if any, are gross or microscopic hematuria
and/or sterile leukocyturia that may be misdiagnosed as
urinary tract infection [12].
Diagnostic imaging
Initial diagnostic testing has to uncover, systematically,
obstruction or stasis, infection, and metabolic abnormalities
(Tables 1 and 2) and profoundly relies on imaging of the
urinary tract. With the availability of minimally invasive
imaging modalities, such as ultrasound and computed
tomography (CT), the latter less used for pediatric patients,
stones are increasingly being detected incidentally during
evaluation of nonspecific symptoms or unrelated problems.
At baseline, however, imaging of the urinary tract has to be
sufficiently thorough to rule out, assertively, stasis or
obstruction related either to a stone or to congenital or
acquired abnormalities of the urinary tract.
The appearance on imaging studies depends upon the
stone’s composition. Those composed of calcium oxalate or
calcium phosphate have a very dense image on conven-
tional radiographs and on CT scans. Struvite (magnesium
ammonium phosphate) and cystine stones are of interme-
diate density, and small stones of all compositions can be
difficult to appreciate by conventional radiography. Uric
acid stones are radiolucent on radiographs, requiring the
administration of contrast agents for adequate visualization,
and have a low density image on CT scans. Stones
composed of indinavir, ceftriaxone, sulfadiazine or matrix
(all infrequent, the latter composed of protein structures as a
matrix for, for example, calcium oxalate stones) are of
variable density and may be difficult to differentiate from
surrounding soft tissue by any modality, including ultra-
sound [13–15].
Stones of all composition, with the exception of drugs
(e.g. indinavir) and matrix (protein), have distinguishing
characteristics of echogenicity and shadowing on ultraso-
nography. Ultrasonography has the additional advantages
of wide availability, avoidance of ionizing radiation, ready
detection of hydronephrosis, and ability to define some
aspects of the anatomy of the urinary tract. However,
ultrasonography is not as sensitive as CT is for the
detection of small stones or stones in the ureter. Indeed,
small stones may not be detectable by routine ultrasound
examination, even when strongly suspected. Measurement
of stone size is less reproducible by ultrasound than by
conventional radiographs or CT, thus maybe reducing its
utility for the monitoring of metabolic stone forming
activity over time. Nevertheless, and as stones as small as
only 1.5–2 mm in diameter can be visualized on
ultrasonography (US), the success of this imaging method
clearly depends on inter-observer and intra-observer
variability and skills.
Most stones can be imaged without the use of contrast
agents. However, when obstruction is a concern, when
radiolucent or low density stones require careful delineation,
or when details of urinary tract anatomy are needed (such as
confirmation of a duplicated collecting system), contrast
agents (CTurography, intravenous pyelography, or retrograde
ureteroscopy/pyelography, or orthograde pyelography) are
usually required.
Individual clinical characteristics, type of stone, and
questions to be addressed should be considered in decisions
regarding the best imaging modality. Ultrasonography is
almost always a good initial choice and, in uncomplicated
situations, may be all that is needed.
The typical stone location is within the renal pelvis and/
or the renal calyces or the ureter and less often within the
bladder. The most common ureteral calcification is a stone
that has migrated down from the kidney. These stones
typically become impacted at anatomic sites of narrowing
and are especially difficult to detect when they overlie
bony structures such as the sacrum. Detection of a ureteral
stone via ultrasonography is difficult, but the stone may
lead to obstruction (hydroureter or hydronephrosis) and
may, thus, be suspected, even if not directly visualized.
Next to that, the color Doppler twinkling artifact can be used
in all sides negative for stones in B mode ultrasonography
[16].
Studies of adult patients have shown that non-contrast-
enhanced CT is more effective than intravenous urography
(IVU) in identifying and locating ureteral stones [10] and
that almost all urinary calculi are now able to be seen with
the appropriate selection of imaging techniques, no matter
where they reside in the urinary tract [17]. However, in
infants and young children, particularly, minimization of
exposure to ionizing radiation, and the occasional need for
sedation with CT, favors the use of ultrasonography or
conventional radiography over CT, whenever they provide
the necessary visualization.
For the detecting and monitoring of nephrocalcinosis,
high-resolution ultrasonography is the optimal imaging
method (Fig. 1). Nephrocalcinosis is classified according
to the anatomic area involved. Medullary nephrocalcinosis
Pediatr Nephrol (2010) 25:403–413 407is differentiated from either cortical nephrocalcinosis (e.g.
in acute cortical necrosis, chronic glomerulonephritis and
chronic graft rejection) or diffuse nephrocalcinosis and is
divided into three subtypes according to the degree of
echogenicity. Thanks to the routine use of ultrasonography
in premature infants and in children at risk, a large number
of conditions are now recognized to be associated with
nephrocalcinosis (Table 2)[ 12].
Some pitfalls in the renal ultrasonography of neonates,
and especially preterm infants, have to be noted: Tamm–
Horsfall protein (THP) deposits within the renal calyces
may look like nephrocalcinosis (Fig. 1). THP deposition,
however, disappears within 1–2 weeks, and follow-up will
show completely normal kidneys. Furthermore, the echo-
genicity of the renal cortex in neonates is physiologically
increased, hence detection of cortical nephrocalcinosis can
be difficult and may become evident only some weeks later
when a rim of cortical calcification becomes visible.
However, diffuse cortical nephrocalcinosis may already be
detectable shortly after birth in patients with suspected
primary hyperoxaluria, and it is directly visible both by US
and X-ray [18]. Medullary nephrocalcinosis can, sono-
graphically, only be diagnosed when increased echogenicity
appears in the area of the renal medulla. Normally, the renal
pyramids are hypoechoic in relation to the cortex.
A plain film of the abdomen is less helpful, as only the
association of hyperechoic pyramids with a posterior
acoustic shadow is a clear sign of nephrocalcinosis. Gross
calcifications are thus required before nephrocalcinosis can
be diagnosed from conventional radiographs.
A comparison of US and CT in induced nephrocalcinosis
in rabbits demonstrated a higher sensitivity for US (96% vs
64%), but a better specificity for CT (96% vs 85%) [19].
Still, renal ultrasonography is the first diagnostic imaging
option in infants and children with suspected stones or
nephrocalcinosis.
a
c
ef
d
b
Fig. 1 a Normal, still
hyperechoic kidney of a preterm
infant; b Tamm–Horsfall kidney;
c medullary nephrocalcinosis
(NC) grade I (mild increase of
echogenicity around the pyrami-
dal border); d medullary NC
grade II (mild increase of echo-
genicity at whole pyramid);
e medullary NC grade III (more
severe hyperechogenicity of
entire pyramid); f diffuse
corticomedullary NC [6]
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Complete urine analysis of a random voided specimen is a
necessary diagnostic evaluation inevery acute stone episode.
Hematuria, white blood cell (WBC) count, pathogens and
urinary protein excretion can easily be determined. Micro-
scopic examination of the urine is important, not only for the
differentiation between glomerular and non-glomerular
hematuria, but also for WBC counts and detection of crystals
such as hexagonal cystine crystals, 2,8 dihydroxy-adenine
and certain drugs (e.g. indinavir urinary crystals [20]). Since
the pH of the urine is a major factor in the formation of
many stones, its measurement—preferably by glass elec-
trode, or, if a pH electrode is not available, by pH paper
with the specific and adequately distinguishable range of
pH 2 to 9—is of utmost importance. Sometimes, it is
advisable to determine a daily profile of both the pH and the
density (specific gravity or osmolality) of the urine. This
may also be used for follow-up, e.g. to assess the effect of
the administration of alkali or to check the patient’s
compliance regarding sufficient fluid intake. The presence
or absence of infection can be addressed by a urine culture.
Chemical analysis includes, apart from creatinine, calci-
um, uric acid, oxalic acid, phosphate [determine tubular
reabsorption of phosphate (TRP) or tubular maximum for
phosphate corrected for glomerular filtration rate (TmP/
GFR)], magnesium and citrate. Cystine is screened for by
nitroprusside test or by chromatography for amino acids. For
all patients, analyses for serum calcium, phosphorus, mag-
nesium, uric acid, alkaline phosphatase, pH, bicarbonate, and
creatinine should be performed. In specific cases further
blood analyses for parathyroid hormone (PTH), vitamin D
metabolites, vitamin A (for patients with hypercalciuria),
serumvitaminB6levelsandplasmaoxalate(forpatients with
primary hyperoxaluria) and, of course, molecular genetic
testing (see Tables 1 and 2) will later be necessary.
Predisposing causes for urolithiasis can be recognized in
>75% of children and adolescents with urinary tract stones
[7, 9]. Accordingly, every young patient with urolithiasis,
and even with the first stone episode, deserves a compre-
hensive examination so that a delay in treatment, and hence
early complication, e.g. acute renal failure in infantile
oxalosis, can be avoided [6, 11]. Infection, obstruction, or
stasis will be identified by the diagnostic evaluation
outlined above. However, systematic detection of predis-
posing metabolic factors requires further testing.
Metabolic factors, among which hypercalciuria, hyper-
oxaluria and hypocitraturia are the most common, are
determined by measurement of relevant urinary solutes and
naturally occurring inhibitors of crystal and stone forma-
Parameter age Normal value per 24 h Remarks
Calcium, all ages <0.1 mmol (<4 mg)/kg See Table 2
Oxalate <0.5 mmol (<45 mg)/1.73 m
2 Primary hyperoxaluria types I/II for constant excessive
elevation, check also urinary glycolate, L-glycerate and
plasma oxalate
Secondary hyperoxaluria: determine intestinal oxalate
absorption and stool. Oxalobacter formigenes colonization.
Normal plasma oxalate different according to laboratory
method, but clearly <8 μmol/l
Citrate
Male >1.9 mmol (365 mg)/1.73 m
2 Hypocitraturia: metabolic acidosis, hypokalemia, calcineurin
inhibitors Female >1.6 mmol (310 mg)/1.73 m
2
Uric acid, all
ages
0.56 mg/dl per GFR Hyperuricosuria: check diet, medication, tumor lysis, inborn
errors of metabolism
Magnesium >0.04 mmol (0.8 mg)/kg FHHNCwithhypomagnesemia and elevated FEMg,S e eT a b l e2
Phosphate TmP/GFR Renal phosphate leakage with low serum phosphate, tumor
lysis syndrome with high serum phosphate <3 months <3.3 mmol/l
<6 months <2.6 mmol/l
2–15 years <2.44 mmol/l
Cystine
<10 years <55 μmol (13 mg)/1.73 m
2 Check morning urine for hexagonal crystals
>10 years <200 (48 mg)
Adults <250, (60 mg)
Cystine solubility threshold 160–320 mg cystine/l at pH 5–7
Table 3 Normal values for 24 h urine collection (there should be
preservative in the container, either thymol 5% in isopropanol, or 2 N
hydrochloric acid (HCl), before collection is started). Repeat collec-
tion after stone has been captured, as ongoing stone formation may
diminish lithogenic excretion parameters. Check urine volume and
creatinine excretion (2 mg/kg±0.8 mg) to ensure adequate collection
[5, 6, 36–41]. FHHNC Familial hypomagnesemia and hypercalciuria
withnephrocalcinosissyndrome,FEMg fractional excretion of magnesium
Pediatr Nephrol (2010) 25:403–413 409tion, such as citrate. Blood levels of calcium and other
analytes, as determinants of urine composition or as
indicators of underlying disorders relevant to stone forma-
tion (such as metabolic acidosis), are also of importance.
Since many urinary components are influenced by dietary
intake, 24 h urine collections (to exclude diurnal fluctuations
related to intake of food and beverages) provide the best
information and also provide an objective assessment of the
child’s daily intake of fluid. Advise the patient or the parent
to maintain the normal fluid intake and the normal dietary
habits, and, meanwhile, 24 h urine should be collected. Next,
avoid urine sampling under parenteral infusions. Also keep
in mind that stones in situ may diminish the excretion of
urinary lithogenic material, as these substances may concur-
rently be absorbed by the stone [21]. For urine collection, a
preservative should ideally be placed directly into the
sampling bottle; however, urine may be collected without
initial preservation, so long as it is kept cool (at 4°C) and
adequately preserved within 24 h [22].
In infants or young children, or in situations where a
24 h urine collection is difficult, random urine measure-
ments, using the ratio of the concentration of each analyte
to that of urine creatinine, provide valuable information.
Again, the best results are obtained if urine is collected
while patients are receiving their usual diets and fluid
intake. Bladder catheterization only for 24 h urine collec-
tion should be avoided, especially for boys.
Erroneous results might be obtained if obstruction or
infection is present, or when stone fragments are being
passed in the urine following a recent stone fragmentation
procedure. Analysis should be deferred until infection has
been treated and until at least 1 month after lithotripsy or
resolution of the obstruction [23].
Normal values for the excretion rates of solutes that are
most often implicated in stone formation are shown in
Tables 3 and 4. However, it has to be kept in mind that such
data clearly show regional and cultural variability, and, so
far, no multi-institutional studies regarding normative data
of pediatric excretion values exist. Specific abnormalities
may dictate a more directed testing. Many children and
adolescents with stones have more than one predisposing
Table 4 Normal values for spot urine samples: creatinine ratios (solute/creatinine). Ratios are more prone to error than are timed samples. Interpret
with respect to daytime, relation to meals, diet, medication, age and regional differences [5, 6, 36–41]( Ca calcium, RTA renal tubular acidosis)
Parameter age Ratio of solute to creatinine Remarks
Calcium mol/mol mg/mg Highest Ca excretion with breast milk feeding, ratio increasing after meals (up to 40%),
by loop diuretics, immobilization and steroids <12 months <2 0.81
1–3 years <1.5 0.53
1–5 years <1.1 0.39
5–7 years <0.8 0.28
>7 years <0.6 0.21
Oxalate mmol/mol mg/g Primary hyperoxaluria types I/II for constant excessive elevation, check also urinary
glycolate, L-glycerate and plasma oxalate. Secondary hyperoxaluria: determine
intestinal oxalate absorption and stool Oxalobacter formigenes colonization
0–6 months <325–360 288–260
7–24 months <132−174 110−139
2−5 years <98−101 80
5−14 years <70−82 60−65
>16 years <40 32
Citrate mol/mol g/g Low with tubular dysfunction: RTA, prematurity, hypokalemia, renal transplantation
0–5 years >0.25 0.42
>5 years >0.15 0.25
Magnesium mol/mol g/g For <2 years, no reliable data
>0.63 > 0.13
Uric acid
>2 years
<0.56 mg/dl (33 μmol/l) per GFR Higher than in adults throughout childhood; no reliable data for age <2 years
(ratio × plasma creatinine)
Table 5 Ten take-home messages
Message
1. Kidney stones/nephrocalcinosis in children are the symptoms of a
disease, not the disease itself
2. About 40% of children with urolithiasis have a positive family history
3. Predisposing causes for urolithiasis can be recognized in 75% of
children and adolescents
4. Unexplained sterile pyuria or recurrent UTI should raise the
suspicion for urolithiasis
5. Gross hematuria may precedemanifesturolithiasis ornephrocalcinosis
6. Nephrocalcinosis is mostly asymptomatic
7. The diagnosis of primary hyperoxaluria is often delayed; early
detection may prevent the development of renal failure
8. Calyceal depositions of Tamm–Horsfall protein are harmless, but
they may mimic nephrocalcinosis in (preterm) neonates
9. Metabolicurine analysis shouldbe performed in24hurine collection
10. Passing stone fragments and UTI may hamper proper metabolic
urine analysis
410 Pediatr Nephrol (2010) 25:403–413factor [24]. With that in mind, it is important to complete
a systematic evaluation, even when the etiology seems
obvious. For example, patients with congenital ureter-
opelvic junction obstruction and stones may have hyper-
calciuria as a second predisposing cause. When an
inherited metabolic disorder is suspected, urine samples
from family members can be of help in the primary
diagnosis, and they are also valuable for detection in
affected family members.
For patients with multiple stones at the onset, or those in
whom there is active stone formation and no abnormalities
have been identified, additional testing can be helpful. This
testing should include a timed (preferably 24 h) urine
collection for a full supersaturation profile [25, 26]. Owing
to day-to-day variationsindietand fluid intake, three separate
determinations on different days have been demonstrated to
providethebestinformation[27]. However, the value of such
computer-based calculation of urinary saturation is debat-
able, as are other determinants of stone risk factors, such the
BONN risk index (BRI, [28, 29]).
In patients with hyperoxaluria, intestinal absorption of
oxalate may be increased, either due to an increased intake
of dietary oxalate, or for enteric reasons such as chronic
inflammatory bowel diseases or a lack of intestinal oxalate-
degrading bacteria [30]. Next to that, the pathology of
intestinal oxalate transporters, e.g. those of the solute carrier
family (SLC26A6), may also play an important role, which
is currently under specific evaluation [31]. To discriminate
the primary from the secondary forms of hyperoxaluria
better, a [
13C2] oxalate absorption test can be performed,
which is safe and reliable in children, as in adults. Intestinal
oxalate absorption is normal in patients with primary
hyperoxaluria and would be significantly increased in those
with dietary or enteric hyperoxaluria [32]. Also, a stool
analysis for the absence of oxalate-degrading bacteria,
especially Oxalobacter formigenes, will give further evi-
dence of the existence of a secondary reason for hyper-
oxaluria [33].
Stone analysis
Qualitative analysis of the stone obtained after spontaneous
stone passage or intervention is one of the most important
diagnostic measures. Only one-third of all stones are
composed of one single substance, and all components
should, hence, be determined. The methods of choice are
infrared spectroscopy or X-ray diffraction. Even amounts of
less then 1 mg can be analyzed. Chemical stone analysis is
inappropriate, as it is prone to errors and is obsolete. The
analytic principle of X-ray diffraction is based on the crystal
structure of the stone substances. With infrared spectroscopy
the loss of energy in the infrared spectrum due to the
circulation of the activated chemical molecules is determined.
The diagrams of either method (the so-called fingerprints)
provide an exact analysis [34].
Recurrent stones should be analyzed again, since the
stone composition may change. After lithotripsy only stone
fragments are available, and these can be recovered by
straining the urine. All fragments should be sent for analysis
to allow additional tests, if needed.
With regard to treatment regimens, all stone components
are of importance. Apart from the main stone components
there are several other substances, such as salts of uric acid
(urates), rare calcium phosphate compositions, protein matrix
stones, stones comprised of medications or their metabolites
(e.g. indinavir, ceftriaxone, sulfadiazine), and artifacts like
gypsum or seeds.
Conclusions
Pediatric urolithiasis is not as rare as is generally believed.
In addition, the prevalence of nephrocalcinosis may be high,
especially in preterm infants [35]. Hence, thorough and
early diagnostic examination is mandatory, for every infant
or child with the first stone event or with nephrocalcinosis
(see Table 5). Following this advice, recurrence of stone
disease or progression of nephrocalcinosis can be pre-
vented, or, taking the worst scenario into consideration,
prevention of early end-stage renal failure (e.g. in patients
with primary hyperoxaluria), can be achieved.
Questions
(Answers appear following the reference list)
1. Which of the following statements are true? Urolithiasis
in children is
a. more frequent than in adults
b. has the same frequency as in adults
c. is less frequent than in adults (approximately 10%
the rate of adults) but is often under-diagnosed
d. more frequent in boys than in girls
e. all of the above are true
2. A metabolic cause of urolithiasis
a. is more likely in children than in adults, since
family history is often positive
b. is unlikely, since the most frequent etiology is UTI
c. can easily be ruled out by family history
d. has the same frequency as in adults
e. does not require consideration, since urolithiasis in
children is so rare
3. Which of the following is not true? Symptoms of
urinary tract stones may include
a. gross hematuria
b. pain
Pediatr Nephrol (2010) 25:403–413 411c. vomiting
d. fever
e. isolated proteinuria
4. Risk factors for urolithiasis in children include
a. dehydration
b. gastro-intestinal disorders (e.g. Crohn’s disease)
c. urinary tract infections
d. diet
e. all of the above are true
5. Primary hyperoxaluria type 1 is
a. a serious disorder that can cause urolithiasis but
also end-stage renal disease
b. the most frequent cause of urolithiasis in children
c. always associated with hypercalciuria
d. only likely if family history is positive
e. a benign condition that does not require treatment
6. Imaging studies in urolithiasis
a. are not important, since clinical details indicate
localization
b. should be thorough, since stones may be small
and are difficult to detect
c. should always include intravenous pyelography
d. should only include abdominal CT, since conven-
tional radiology is mostly insufficient
e. all of the above are true
7. Which of the following are true? The investigation of
metabolic causes in children should include
a. hypercalciuria
b. hypocitraturia
c. hypertriglyceridemia
d. phenylketonuria
e. cystinuria
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Answers
1. Correct answers are c and d:
The incidence of urolithiasis in childhood is believed to be
approximately 10% of that in adults, which is around 5% in
industrialized countries [2]. As a significant proportion of patients
remains undiagnosed or misdiagnosed (incidental discovery is reported
in 15–40%), numbers should be interpreted with caution. Urolithiasis
appears in all age groups of children, but a male predominance
analogous to that in adult patients is observed.
2. Correct answer is a:
About 40% of children with urolithiasis have a positive family
history of kidney stones, and most of the children have a metabolic
background of stone disease. Hence, specific and intensive diagnostic
examination is necessary for every child experiencing even a single
kidney stone to prevent recurrence of disease or even a disastrous
outcome, with kidney failure and end-stage renal disease.
3. Correct answer is e:
The mostcommonsymptomofurolithiasisisabdominalpain,inolder
children clearly identifiable as colicky pain, in infants and children,
however, only recognized as “non-specific” abdominal pain and thus
difficult to differentiate from acute appendicitis, etc. Unexplained sterile
pyuria or recurrent urinary tract infections should raise the level of
suspicion for urolithiasis, especially in the younger child. Gross or
microscopic (non-glomerular) hematuria and, more rarely, flank tender-
ness or urinary retention, are other symptoms encountered. Hematuria
may be present for some time before urolithiasis or nephrocalcinosis
becomes manifest. Sometimes, there are secondary gastro-intestinal tract
symptoms, such as vomiting, flatulence or constipation.
4. Correct answer is e:
Regarding the risk of nephrolithiasis or nephrocalcinosis, particular
attention has to be paid to nutrition or specific diets, fluid intake
(dehydration), medications (vitamins D/A, steroids, diuretics, etc.) and
any mineral supplementation. Children with chronic bowel disease
(e.g. Crohn’s disease, cystic fibrosis, post-bowel resection), neuro-
logic disorders (anticonvulsant drugs, low fluid intake) or with
anomaliesoftheurinarytractpredisposingtourinestasisandurinarytract
infection (neurogenic bladder, ileal loops, megaureter, megacalycosis,
hydronephrosis) are at special risk of stone formation.
5. Correct answer is a:
Primary hyperoxaluria type I is an autosomal-recessive inherited
disorder which leads to recurrent nephrolithiasis and/or progressive
nephrocalcinosis and can lead to early end-stage renal failure in those
patients with severe symptoms (infantile oxalosis).
6. Correct answer is b:
Initial diagnostic testing has to uncover obstruction or stasis,
infection, and metabolic abnormalities systematically (Table 1), and it
relies profoundly on imaging of the urinary tract. With the availability of
minimally invasive imaging modalities such as ultrasound and CT, the
latter less used for pediatric patients, stones are being increasingly
detected incidentally during evaluation of nonspecific symptoms or
unrelated problems. At baseline, however, imaging of the urinary tract
has to be sufficiently thorough to rule out, assertively, stasis or
obstruction related either to a stone or to congenital or acquired
abnormalities of the urinary tract. Intravenous urography is not a
method of choice for the pediatric patient.
7. Correct answers are a, b and e:
Chemical analysis includes, apart from creatinine, calcium, uric acid,
oxalic acid, phosphate, magnesium and citrate. Cystine is screened for by
nitroprusside test or by chromatography for amino acids. For all patients,
analysis of serum calcium, phosphorus, magnesium, uric acid, alkaline
phosphatase, pH, bicarbonate, and creatinine should be performed.
Pediatr Nephrol (2010) 25:403–413 413